We recently published a list of Did Jim Cramer Get These 23 Stocks Right?. In this article, we are going to take a look at ...

Problematic software has been the cause of multiple infusion pump recalls in the medical device industry over the past few ...

The Davenport Value & Income Fund (DVIPX) generated a -4.18% total return in the fourth quarter of 2024. Click here to read ...

Becton, Dickinson and Company Price Performance Becton, Dickinson and Company stock opened at $230.63 on Monday. Becton, Dickinson and Company has a 1 year low of $218.75 and a 1 year high of $251.99.

Becton Dickinson (BDX) announced the first patient treated in an investigational device exemption clinical trial intended to advance BD’s ...

Proficio Capital Partners LLC bought a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during ...

Medical-device maker Becton Dickinson and Co. accused a former area sales director of bolting to a competitor in violation of ...

BD treated the first subject in the trial with GalaFLEX LITE Scaffold for reducing the recurrence of CC during breast ...

According to Benzinga Pro, Becton Dickinson's peer group average for short interest as a percentage of float is 4.24%, which ...

The Food and Drug Administration has identified a Class I recall of Becton, Dickinson and Company BD Alaris Systems Manager and BD Care Coordination Engine Infusion Adapters due to reports that ...

Shares of Becton Dickinson & Co. BDX slipped 1.11% to $224.92 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.76% to ...

Learn more about whether Becton, Dickinson and Company or GE HealthCare Technologies Inc. is a better investment based on ...